Concepedia

George L. Spitalny

GL

38

Publications

3.2K

Citations

26

H-Index

1973

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Trudeau Institute

Elusys Therapeutics (United States)

New York University

Princeton University

George L. Spitalny is an author at Bristol-Myers Squibb (United States) specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

1973–2016

38

Publications

38

MEDI-563, a humanized anti–IL-5 receptor α mAb with enhanced antibody-dependent cell-mediated cytotoxicity function

Roland Kolbeck, Alexander Kozhich, Masamichi Koike et al. · Journal of Allergy and Clinical Immunology · 2010 · 567 citations

, , +5

Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities.

George L. Spitalny, Edward A. Havell · The Journal of Experimental Medicine · 1984 · 368 citations · Full text

, , +21

Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-<i>gamma</i>.

Henry W. Murray, George L. Spitalny, C F Nathan · The Journal of Immunology · 1985 · 358 citations

Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti–IL-5 receptor α antibody, in a phase I study of subjects with mild asthma

William W. Busse, Rohit Katial, David Gossage et al. · Journal of Allergy and Clinical Immunology · 2010 · 276 citations

, , +8

Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linker.

Robert S. Greenfield, Takushi Kaneko, A Daues et al. · PubMed · 1990 · 179 citations

, , +16

Rows per page

1–5 of 38